Related Experiment Video
Updated: Jul 16, 2026
09:44
Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis
Published on: June 13, 2021
The yeast Pdr5p multidrug transporter: how does it recognize so many substrates?
John Golin1, Suresh V Ambudkar, Leopold May
1Department of Biology, The Catholic University of America, Washington, DC 20064, USA. golin@cua.edu
Biochemical and Biophysical Research Communications
|February 24, 2007
Summary
Multidrug efflux pumps, like yeast Pdr5p, present challenges in treating diseases. Pdr5p utilizes multiple binding sites with distinct chemical properties, but all substrates share a common size requirement independent of hydrophobicity.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Multidrug transporters are crucial in medicine, impacting infectious disease and cancer treatments.
- Efflux pumps exhibit broad substrate specificity, recognizing diverse chemical structures.
- ATP-binding cassette (ABC) transporters, like yeast Pdr5p, are key players in cellular efflux mechanisms.
Purpose of the Study:
- To investigate the substrate recognition mechanisms of the yeast Pdr5p efflux pump.
- To elucidate the role of substrate-binding sites in Pdr5p's broad substrate specificity.
- To determine the physicochemical properties governing Pdr5p substrate transport.
Main Methods:
- Utilizing biochemical assays to characterize Pdr5p activity.
- Employing structural biology approaches to identify substrate-binding pockets.
- Performing structure-activity relationship studies with various Pdr5p substrates.
Main Results:
- The yeast Pdr5p efflux pump possesses at least three distinct substrate-binding sites.
- Each binding site appears to employ different chemical properties for compound recognition and transport.
- A conserved size constraint, independent of hydrophobicity, is a universal requirement for Pdr5p substrates.
Conclusions:
- Pdr5p employs a multi-site binding strategy to accommodate structurally diverse substrates.
- Substrate size is a critical determinant for transport by Pdr5p, overriding other chemical properties.
- Understanding these mechanisms can inform strategies to overcome multidrug resistance in clinical settings.
Related Concept Videos
01:06Carrier-Mediated Transport
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
01:28Yeast Signaling
Yeasts are single-celled organisms, but unlike bacteria, they are eukaryotes (cells with a nucleus). Cell signaling in yeast is similar to signaling in other eukaryotic cells. A ligand, such as a protein or a small molecule released from a yeast cell, attaches to a receptor on the cell surface. The binding stimulates second-messenger kinases to activate or inactivate transcription factors that further regulate gene expression. Many of the yeast intracellular signaling cascades have similar...
01:31ABC Transporters: Exporter
ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
01:16Facilitated Diffusion
The plasma membrane, a critical structure in cellular biology, houses an array of transporters, or carrier proteins, interspersed within its lipid bilayer. These proteins play a crucial role in solute transport through facilitated diffusion, a form of passive diffusion that uses transporters to move the molecules across the membrane.
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
01:44The Significance of Membrane Transport
The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...